Jennifer Zachary - Jun 2, 2023 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Role
Director
Signature
/s/ Patrick J. Christmas as attorney-in-fact
Stock symbol
RGNX
Transactions as of
Jun 2, 2023
Transactions value $
$0
Form type
4
Date filed
6/6/2023, 05:11 PM
Previous filing
May 5, 2023
Next filing
Jan 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGNX Common Stock Award $0 +3.49K +57.91% $0.00 9.51K Jun 2, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGNX Stock Options (Right to Buy) Award $0 +17.9K $0.00 17.9K Jun 2, 2023 Common Stock 17.9K $19.72 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer.
F2 The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer.